Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - LondonMetric Property Plc
-
NAHREP Announces 2025 Top 250 Latino Mortgage Originators
-
Form 8.3 - Life Science REIT Plc
-
Dave & Buster’s Entertainment, Inc. to Report First Quarter 2025 Financial Results on June 10, 2025
-
TruGolf Links Celebrates 1-Year Anniversary at New York International Franchise Expo
-
Signing Day Sports Progresses Transaction and Executes Definitive Agreement with BlockchAIn Digital Infrastructure, a Profitable Data Hosting Company
-
JFB Construction Holdings Executes Over $69.5 Million in Contracts to Date in 2025
-
Form 8.3 - GlobalData Plc
-
Form 8.3 - Craneware Plc
-
Form 8.3 - Assura Plc
-
Orange Bank Appoints Stephanie Melowsky to Lead Legal Services Division, Overseen by Industry Veteran Joseph Ruhl
-
LKQ Publishes 2024 Global Sustainability Report
-
Beyond Oil Reports Financial Results for the First Quarter of 2025
-
Helport AI to Participate in the Baird Global Consumer, Technology & Services Conference on June 3-5, 2025
-
Helport AI to Participate in the Baird Global Consumer, Technology & Services Conference on June 3-5, 2025
-
Flare Therapeutics to Participate in Jefferies Global Healthcare Conference
-
Ernexa Therapeutics Announces New Data to be Presented at ASCO Annual Meeting 2025
-
Miata Metals Confirms Gold in Bedrock at the Sela Creek Gold Project in Suriname
-
Plymouth Rock Home Assurance Corporation Names Colleen Finn as Chief Marketing Officer
-
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
-
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
-
Vittoria Biotherapeutics to Share Trials-in-Progress Presentation from Phase 1 Study of VIPER-101 at ASCO 2025 Annual Meeting
-
Alpha Tau to Present at Jefferies Global Healthcare Conference
-
IBN Initiates Coverage of Lahontan Gold Corp.
-
Volcon ePowersports Obtains Floor Plan Program with Dealer Direct Financing
-
Primech A&P Secures New Contracts and Extensions Worth Over $2.6 Million for Q1 2025
-
MACOM Showcases Advanced RF and Microwave Solutions at IMS 2025
-
MMA.INC and UFC Gym Group Celebrate Sold-Out Inaugural Finale Fight Night at Flagship Huntington Beach, California Gym
-
Eos Energy Secures Strategic Order for Faraday Microgrid’s Project in California
-
FDCTech Engages E.F. Hutton to Lead Capital Raise and Advise on Uplisting to a Senior Exchange
-
Snail, Inc. to Present at the Noble Capital Markets Emerging Growth Conference on June 4, 2025 at 2:30 PM ET
-
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
-
iTeos Therapeutics Announces Its Intention to Wind Down Operations
-
A Smarter Way to Pay: Giftify’s CardCash Launches Buy Now, Pay Later with ZIP
-
Penlink Introduces New Media Intelligence Platform Powered by Generative AI
-
Primech A&P Secures New Contracts and Extensions Worth Over $2.6 Million for Q1 2025
-
HCVC leads kyron.bio €5.5M round to use glycan engineering for advanced drug design
-
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
-
xSuite North America to Host 2025 User Conference in Boston
-
Total number of voting rights and share capital in ROCKWOOL A/S
-
Bitcoin Whales Strike Again, PAIRMiner Reports Surge in User Registrations as Public Seeks Digital Asset Dividends
-
VEEPEEN Launches with Viral Momentum, Crosses 3,000 Holders Amid VEEPEEN Meme Surge
-
Yahoo DSP Onboards Comscore’s AI-Powered ID-Free Audiences for Efficient and Privacy-Centric Campaign Activation
-
69% of Organizations Breached by Ransomware Over Past Year, Delinea Report Finds
-
SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy
-
NEXBOARD’s Nanotechnology Successfully Resists Over 2,000⁰F for Over 80 Minutes in Internal Lab Test
-
Preferred Travel Group Names Philipp Weghmann Chief Development Officer and President of Beyond Green
-
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
-
CareCloud Announces Results from Annual Shareholders’ Meeting
-
New Episode Now Streaming on Alpha Liquid Podcast, How to Access Powerful AI Agent Tools With Eliza Systems

